These and other trends are reported in Pharmaceutical Packaging, a new study from The Freedonia Group, Inc.. Demand for these packaging products in the U.S. (including Puerto Rico) is forecasted to increase 7% annually to more than $11 billion by 2010 (see chart).
The report says, "Pharmaceutical blister packaging will maintain the largest share of sales based on its adaptability to unit dose, clinical trial, sample, compliance, institutional, and over-the-counter container formats."
Pharmaceutical Packaging predicts that prefillable inhalers and syringes will help drive sales of primary containers. It also expects RFID bar-coded labels and accessories to post solid sales gains, reaching $2.3 billion by 2010. The 303-page study is available for $4,400 by contacting Corinne Gangloff at 440/684-9600.
The report says, "Pharmaceutical blister packaging will maintain the largest share of sales based on its adaptability to unit dose, clinical trial, sample, compliance, institutional, and over-the-counter container formats."
Pharmaceutical Packaging predicts that prefillable inhalers and syringes will help drive sales of primary containers. It also expects RFID bar-coded labels and accessories to post solid sales gains, reaching $2.3 billion by 2010. The 303-page study is available for $4,400 by contacting Corinne Gangloff at 440/684-9600.
